HLA-G has been identified as a cervical cancer stem cell (CCSC)-specific marker, and targeting HLA-G and its related signaling pathways may offer a novel strategy for CCSC-targeted therapy (124). This evidence concerns the gene HLA-G and cervical carcinoma.